Bridging Synthetic Immunology and Genome Editing to Advance CAR-T Cell Therapies

Session moderated by Lekshmi Santhosh

The novel biology of CAR-T cells have transformed the treatment of extremely aggressive cancers. In this talk, Julia Carnevale and Justin Eyquem describe how rewiring the biology of immune cells can help improve outcomes for patients with aggressive cancers. They will explore how exciting tools like genomic editing harness the power of CRISPR-based discovery platforms to identify novel gene targets. 

Speakers
Julia Carnevale, MD, is an assistant professor in the Division of Hematology and Oncology at UCSF Health and an affiliate investigator at the Gladstone Institutes. She treats patients with gastrointestinal cancers and also performs research into finding novel therapies for these diseases.

Justin Eyquem, PhD, is an assistant professor in the Departments of Medicine and Microbiology and Immunology at UCSF and an affiliate investigator at the Gladstone Institutes. He joined UCSF as a Parker fellow in 2019 and became assistant professor at the Gladstone Institute of Genomic Immunology in 2021. 

How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue.)
Lunch will be provided.

On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/97203014505?pwd=SEMreEVPZ2gyZUVIQTFyL0xoRlk0Zz09

By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833  or +1 346 248 7799  or +1 312 626 6799  or
+1 646 558 8656  or +1 253 215 8782  or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU

The session will be recorded for later play. See all past recordings.